Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q41603300)
Watch
English
Sulfonylureas
scientific article published on September 1997
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
9314012
retrieved
4 October 2017
review article
1 reference
stated in
Europe PubMed Central
title
Sulfonylureas
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9314012
retrieved
4 October 2017
author name string
Zimmerman BR
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9314012
retrieved
4 October 2017
publication date
1 September 1997
1 reference
stated in
Europe PubMed Central
PubMed ID
9314012
retrieved
4 October 2017
published in
Endocrinology and Metabolism Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed ID
9314012
retrieved
4 October 2017
volume
26
1 reference
stated in
Europe PubMed Central
PubMed ID
9314012
retrieved
4 October 2017
issue
3
1 reference
stated in
Europe PubMed Central
PubMed ID
9314012
retrieved
4 October 2017
page(s)
511-522
1 reference
stated in
Europe PubMed Central
PubMed ID
9314012
retrieved
4 October 2017
cites work
A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. European NIDDM Policy Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Factors for development of secondary failure to sulfonylurea drugs in non-insulin-dependent diabetes mellitus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical profile of glimepiride
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute actions of sulfonylurea drugs during long-term treatment of NIDDM.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sulfonylureas activate glucose transport and protein kinase C in rat adipocytes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Continuous versus intermittent sulphonylurea therapy in non-insulin-dependent diabetes mellitus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of efficacy, secondary failure rate, and complications of sulfonylureas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizide.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative tolerability profiles of oral antidiabetic agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The mechanism of action of the hypoglycemic sulfonamides: a concept based on investigations in animals and in human beings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sulfonylurea Enhances Insulin-Induced Acetyl Coenzyme A Carboxylase Activity in Rat Adipocytes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sulfonylureas. Why, which, and how?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sulfonylurea receptors and mechanism of sulfonylurea action
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Insulin plus a Sulfonylurea Agent for Treating Type 2 Diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Problems and pitfalls of sulphonylurea therapy in older patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved effect of tolbutamide when given before food in patients on long-term therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic Patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved effect of glibenclamide on administration before breakfast.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antihyperglycaemic agents. Drug interactions of clinical importance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Individual sulfonylureas and serious hypoglycemia in older people.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of the sulfonylureas on muscle glucose homeostasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of secondary failure to sulfonylureas in type 2 diabetics. A retrospective study for 1976-1987
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hypoglycemia associated hospitalizations in a population with a high prevalence of non-insulin-dependent diabetes mellitus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impaired effect of sulfonylurea following increased dosage.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hemobiological properties of gliclazide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970264-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0889-8529(05)70264-4
1 reference
stated in
Europe PubMed Central
PubMed ID
9314012
retrieved
4 October 2017
PubMed ID
9314012
1 reference
stated in
Europe PubMed Central
PubMed ID
9314012
retrieved
4 October 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit